4Savelli G,Lucignani G,Seregni E,et al.Feasibility of somatostatin receptor scintigraphy in the detection of occult primary gastro-enteropancreatic (GEP) neuroendocrine tumours[J].Nucl Med Commun,2004,25(5):445-448.
1Ahuja V, Coleman RE, Herndon J, et al.Prognostic significance of FDG-PET imaging in patients with non-small cell lung cancer. Cancer, 1998, 83: 918-924.
2Kubota K, Tada M, Yamada S, et al. Comparison of the distribution of 18F-fluoromisonidazole, deoxyglucose and methionine in tumour tissue. Eur J Nucl Med, 1999, 26: 750-757.
3Koh WJ, Bergman KS, Rasey JS, et al. Evaluation of oxygenation status during fractionated radiotherapy in human non-small cell lung cancers using 18F-fluoromisonidazole positron emission tomography. Int J Radiat Oncol Biol Phys,1998, 33: 391-398.
4Rasey JS, Koh WJ, Evans ML, et al. Quantifying regional hypoxia in human tumors with positron emission tomography of 18F-fluoromisonidazole: a pretherapy study of 37 patients.Int J Radiat Oncol Biol Phys, 1996, 36: 417-428.
5Lehtio K, Oikonen V, Nyman S, et al. Quantifying tumor hypoxia with 18F-fluoroerythronitroimidazole (18 F-FETNIM) and PET using the tumor to plasma ratio. Eur J Nucl Med Mol Imaging, 2003, 30: 101-108.
6Takahashi N, Fujibayashi Y, Yonekura Y, et al.Evaluation of 62Cu labeled diacetyl-bis ( N-4-methylthiosemicarbazone) as a hypoxic tissue tracer in patients with lung cancer. Ann Nucl Med, 2000, 14: 323-328.
7Siim BG, Laux WT, Rutland MD, et al. Scintigraphic imaging of the hypoxia marker 99 Tcm-labeled 2,2'- ( 1,4-diaminobutane ) bis (2-methyl-3-butanone) dioxime (99Tcm labeled HL91; Prognox): non-invasive detection of tumor response to the antivascular agent 5,6-dimethylxanthenone-4-acetic acid. Cancer Res, 2000, 60: 4582-4588.
8Chao KS, Bosch WR, Mutic S, et al. A novel approach to overcome hypoxic tumor resistance:Cu-ATSM-guided intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys, 2001,49: 1171-1182.
9Haberkom U, Strauss LG, Dimitrakopoulou A,et al. PET studies for fluorodeoxyglucose metabolism in patients with recurrent colorectal tumors receiving radiotherapy. J Nucl Med,2001, 32:1485-1490.
10Erdi YE, Macapinlac H, Rosenzweig KE, et al.Use of PET to monitor the response of lung cancer to radiation treatment. Eur J Nucl Med,2000, 27: 861-866.
